The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|April 2, 2013
- Pharmaceutical Technology-04-02-2013
- Volume 37
- Issue 4
Pharmaceutical Technology, April 2013 Issue (PDF)
Click the title above to open the Pharmaceutical Technology April 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 13 years ago
Strategic Partnering for Manufacturingover 13 years ago
Advancing Flow Chemistry in API Manufacturingover 13 years ago
Report from Latin Americaover 13 years ago
Fine-Chemical Producers Make Targeted Investmentsover 13 years ago
Evaluating Equipment Utility and Innovationover 13 years ago
Previewing Packaging Innovationsover 13 years ago
Method Validation by Design to Support Formulation Developmentover 13 years ago
Bio/Pharmaceutical Facility Design and Operation: A PrimerAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
2
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
AI Formulation: Regulators Want Data
5